Tensha Therapeutics' Acquisition

Tensha Therapeutics was acquired by Roche Holding on January 11, 2016.

Tensha Therapeutics is a biotechnology company developing small molecule bromodomain inhibitors to regulate disease-linked gene transcription. Tensha noted that its lead preclinical program is intende…

Articles about Tensha Therapeutics' Acquisition: